Get Real Time Here
| Open5.500 | Close5.980 |
| Vol / Avg.409.079K / 450.699K | Mkt Cap375.093M |
| Day Range5.486 - 6.150 | 52 Wk Range5.010 - 11.180 |
Compass Pathways Stock (NASDAQ:CMPS), Quotes and News Summary
Compass Pathways Stock (NASDAQ: CMPS) stock price, news, charts, stock research, profile.
| Open5.500 | Close5.980 |
| Vol / Avg.409.079K / 450.699K | Mkt Cap375.093M |
| Day Range5.486 - 6.150 | 52 Wk Range5.010 - 11.180 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.430 | -0.670 | -0.2400 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-22 | Cantor Fitzgerald | Jonathan Fiore | Reiterates | OverweightOverweight | Maintains | - | 21.00 |
| 2023-08-22 | Canaccord Genuity | Sumant Kulkarni | Maintains | BuyBuy | Lowers | 60.00 | 50.00 |
| 2023-08-17 | Cantor Fitzgerald | Jonathan Fiore | Reiterates | OverweightOverweight | Maintains | - | 21.00 |
| 2023-08-04 | HC Wainwright & Co. | Patrick Trucchio | Reiterates | Buy | Maintains | - | 120.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| CMPS | Compass Pathways | 9.39% | 375.1M |
| IMNM | Immunome | -1.79% | 329M |
| ORTX | Orchard Therapeutics | -0.65% | 366.9M |
| KALV | KalVista Pharma | 0% | 308.6M |
| CELC | Celcuity | -1.07% | 374.3M |
How do I buy Compass Pathways (CMPS) stock?
You can purchase shares of Compass Pathways (NASDAQ: CMPS) through any online brokerage.
Who are Compass Pathways's (CMPS) competitors?
Other companies in Compass Pathways’s space includes: Immunome (NASDAQ:IMNM), Orchard Therapeutics (NASDAQ:ORTX), KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC) and Voyager Therapeutics (NASDAQ:VYGR).
What is the target price for Compass Pathways (CMPS) stock?
The latest price target for Compass Pathways (NASDAQ: CMPS) was reported by Cantor Fitzgerald on Tuesday, August 22, 2023. The analyst firm set a price target for 21.00 expecting CMPS to rise to within 12 months (a possible 246.53% upside). 18 analyst firms have reported ratings in the last year.
Current Stock Price for Compass Pathways (CMPS)?
The stock price for Compass Pathways (NASDAQ: CMPS) is $6.06 last updated December 7, 2023 at 11:55 PM UTC.
Does Compass Pathways (CMPS) pay a dividend?
There is no dividend information for Compass Pathways.
When is Compass Pathways (NASDAQ:CMPS) reporting earnings?
Compass Pathways’s Q4 earnings are confirmed for Tuesday, February 27, 2024.
Is Compass Pathways (CMPS) going to split?
There is no upcoming split for Compass Pathways.
What sector and industry does Compass Pathways (CMPS) operate in?
Compass Pathways is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.